(Press-News.org) A UC San Francisco-led study has for the first time identified genetic variants that predict whether patients will respond to treatment for preterm birth, a condition that affects one in 10 infants born in the United States.
The findings are critical because no medication is available in the U.S. to treat preterm birth. Last year, the Food and Drug Administration (FDA) pulled the only approved therapy to help prevent this condition, a synthetic form of progesterone sold under the brand name Makena, from the market, citing ineffectiveness.
The new research found that pregnant individuals with high levels of mutations in certain genes – specifically those associated with involuntary muscle contraction – were less likely to respond to the treatment. Screening for the mutations could allow doctors to target the medication to those most likely to benefit, the authors suggest.
“This study calls for a precision framework for future drug development,” said the study’s senior author, Jingjing Li, PhD, associate professor in UCSF’s Department of Neurology and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research. “In addition to understanding drug effects based on population averages, we also need to take into account the drug response of each individual patient and ask why some respond and some don’t.”
The study, which was done in collaboration with Stanford University, appears Jan. 19, 2024, in the journal Science Advances.
New genes associated with preterm birth
Preterm birth, or babies born alive prior to 37 weeks of gestation, is the leading cause of infant mortality and affects some 15 million pregnancies worldwide each year. Preterm birth also leads to a range of long-term health consequences including breathing problems, neurological impairments such as cerebral palsy, developmental disabilities, visual and hearing impairments, heart disease and other chronic illnesses.
To conduct the study, researchers developed a machine-learning framework to analyze genomes of 43,568 patients that had spontaneous preterm births. The approach uncovered genes that had not previously been known to be associated with preterm birth.
They then examined mutations in the genes among those who had received the progesterone treatment Makena. The FDA had approved the drug in 2011 after a single clinical trial but took it off the market last spring after concluding the drug didn’t work.
The decision left doctors without an approved medication for preterm birth and frustrated those who had found it effective for a subset of their patients. This posed the question: Could there be a genetic reason why progesterone therapy worked for some, but not for others?
The researchers discovered that the patients in the group with low levels of mutations in the genes associated with muscle contractions were more likely to respond to Makena, but those with higher levels tended not to respond.
The finding indicates a personalized medicine approach that involves genetic screening could lead to successful results in patients without a high burden of those mutations.
“Progesterone therapy was the only treatment for recurrent preterm birth over the past decade, and its recent withdrawal by the FDA has left a void in the medication options available for preterm birth patients,” said the study’s first author, Cheng Wang, PhD, a postdoctoral scholar at UCSF.
“In previous clinical practice, we did see that many patients benefited from progesterone therapy,” Wang said. “We probably should reevaluate its efficacy, if we can identify those who respond positively to the treatment.”
The researchers included a cohort of African American patients in the study to determine whether the findings applied broadly across different races. Black women in the U.S. are almost twice as likely to give birth prematurely than white women.
They found the genetic burden did not vary by race. This suggests the high rate of preterm birth among Black mothers may be due primarily to environmental factors such as elevated stress hormones, health care biases and lack of prenatal care.
A new type of precision medicine
The researchers then went beyond that finding to identify new targets and potential therapies to treat preterm birth. They screened more than 4,000 compounds and homed in on 10 that were predicted to interact with the genes associated with preterm birth.
Many of these therapeutic compounds are already being used to treat cancer and other diseases, which means that these drugs could possibly be repurposed to help prevent preterm labor.
A top candidate is the small molecule RKI-1447, a drug that is currently being used to treat cancer, glaucoma and fatty liver disease. Additional study of the potential of these molecules in treating preterm birth is needed.
Funding and disclosures: This work was supported by National Institute of General Medical Sciences (R35GM142983) and the Marcus Program in Precision Medicine Innovation at UCSF. The study was also funded by the March of Dimes Prematurity Research Center at Stanford University School of Medicine, the Stanford Maternal & Child Health Research Institute and the National Institutes of Health (grants HD092316 and HL160018). Li is co-founder and a member of the scientific advisory board of the genomics-based technology company SensOmics Inc.
About UCSF: The University of California, San Francisco (UCSF) is exclusively focused on the health sciences and is dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. UCSF Health, which serves as UCSF's primary academic medical center, includes top-ranked specialty hospitals and other clinical programs, and has affiliations throughout the Bay Area. UCSF School of Medicine also has a regional campus in Fresno. Learn more at https://ucsf.edu, or see our Fact Sheet.
###
Follow UCSF
ucsf.edu | Facebook.com/ucsf | YouTube.com/ucsf
END
Genetic discovery reveals who can benefit from preterm birth therapy
2024-01-23
ELSE PRESS RELEASES FROM THIS DATE:
Strong links found between Long COVID and ME/CFS: Otago study
2024-01-23
People suffering from Long COVID or Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) could benefit from a coordinated treatment strategy, a new University of Otago study has found.
The pilot study, published in Scientific Reports, a Nature journal, has confirmed what researchers have suspected for some time: the two conditions are closely related.
Lead author Emeritus Professor Warren Tate says the research - the first comparative molecular study of the immune cell proteins of both conditions - “strongly affirms” the link between the two.
“This means information from study of the pathophysiology ...
MIT Press’s Direct to Open reaches annual funding goal, opens access to full list of 2024 monographs
2024-01-23
Now in its third year of operation, Direct to Open (D2O) is proud to announce that it has reached its full funding goal in 2024 and will open access to 79 new monographs and edited book collections this year. What makes this year noteworthy is that this is the first year in which D2O has been fully funded by its November 30 deadline and will not require an extension through the end of the fiscal year.
“Reaching our overall funding goal – in full and on time – is a major milestone in developing a sustainable open ...
Health: Routine health checks associated with decreased risk of death
2024-01-23
Attending an NHS Health Check appointment — a preventative screening programme offered for free in the UK — is associated with both a decreased risk of dying and a decreased risk of several diseases, including dementia and liver cirrhosis. The results, published in BMC Medicine, suggest that the NHS Health Check and other similar preventative programmes can be effective at reducing a population’s overall risk of long-term disease.
The NHS Health Check is a preventative screening programme designed to identify individuals at risk for heart disease, stroke, diabetes, and kidney disease. Healthy ...
Energy drinks linked to poor sleep quality and insomnia among college students
2024-01-23
Knocking back energy drinks is linked to poor quality sleep and insomnia among college students, finds a large Norwegian study published in the open access journal BMJ Open.
And the higher the frequency of consumption, the fewer hours of nightly shut eye the students clocked up. But even just the occasional can—1-3 times a month—is linked to a heightened risk of disturbed sleep, the findings indicate.
Energy drinks contain an average caffeine content of 150 mg per litre as well as sugar, vitamins, minerals and amino acids in varying quantities, note the researchers. Marketed as mental and physical pick-me-ups, ...
Men with inflammatory joint disease less likely to be childless than healthy peers
2024-01-23
Men with inflammatory joint disease, such as rheumatoid arthritis, are less likely to be childless and have more children than their healthy peers, suggests research published online in the Annals of the Rheumatic Diseases.
As yet unknown factors associated with developing the disease and/or its treatment might influence fertility, suggest the researchers.
Autoimmune diseases are on the rise in the West, and impaired fertility has been reported in Norwegian women with inflammatory joint diseases. But only a few studies looking at the potential impact on men’s fertility have ...
Fastest growth in childhood overweight/obesity in England among 11-15 year olds
2024-01-23
The fastest and highest growth in the prevalence of childhood obesity in England has been among 11-15 year olds, rising from 30% in 1995 to 38% in 2019, finds a detailed analysis of national data, published online in the Archives of Disease in Childhood.
But the inequality gap in rates has deepened, driven primarily by differences in deprivation, gender, family structure, ethnicity and parental education, the analysis reveals.
And the current cost of living crisis is set to aggravate these disparities, putting even more disadvantaged children at risk, warn the study authors.
England is projected to have the highest prevalence of obesity in ...
A “radically different” way of looking at Parkinson’s Disease
2024-01-23
TORONTO – An international research team led by Krembil Brain Institute Neurologist and Senior Scientist, Dr. Anthony Lang, has proposed a new model for classifying Parkinson’s disease (PD).
In recent decades, researchers have uncovered several biological factors that underlie PD. Key factors include a build up of the protein α-synuclein in the brain, which leads to neuron degeneration, and genetic factors that increase one’s risk of developing the disease. They have also begun to develop reliable methods to test for these factors, called biomarkers, in living patients.
Despite these advancements, ...
Could bizarre visual symptoms be a telltale sign of Alzheimer's?
2024-01-23
A team of international researchers, led by UC San Francisco, has completed the first large-scale study of posterior cortical atrophy, a baffling constellation of visuospatial symptoms that present as the first symptoms of Alzheimer’s disease. These symptoms occur in up to 10% of cases of Alzheimer’s disease.
The study includes data from more than 1,000 patients at 36 sites in 16 countries. It publishes in the Lancet Neurology on Jan. 22, 2024.
Posterior cortical atrophy (PCA) overwhelmingly ...
Blue tit population booms with moths on the menu - study
2024-01-23
The importance of moth caterpillars for common garden birds has been revealed in a new study.
Researchers found that years when moth numbers were up resulted in increased population growth for the blue tit.
The results, derived from 23 years worth of bird and insect population data, are published today (Tuesday, 23 January) in Ecology Letters.
Dr Luke Evans, of the University of Reading, led the research. He said: "Insect abundance directly impacts songbird numbers from year to year. When moth caterpillars are large in number, blue tit parents can easily find food for their demanding chicks. When moth numbers crash it gets much harder for birds to find enough insects and raise ...
UW researchers uncover news clues about the cause of common birth defects
2024-01-23
MADISON, WI.-- Cleft lip and palate are the most common craniofacial birth defects in humans, affecting more than 175,000 newborns around the world each year. Yet despite decades of research, it’s still not known what causes most cases or what can be done to prevent them. But a recent study from the University of Wisconsin School of Veterinary Medicine (SVM) has uncovered new information about orofacial development in mice that researchers believe could one day help reduce the risk of these birth defects in humans.
Published this week in the Proceedings of the National Academy of Sciences ...